--Nanobiotix initiated with an Outperform at Leerink » 06:17 NBTX, JNJ --Quantum-Si initiated with bullish view at H.C. Wainwright, here's why » 06:08 QSI --Joby Aviation partners with ANA Holdings, NRE for vertiports in Japan » 05:16 JOBY --Bluebird Bio just upgraded at Morgan Stanley, here's why » 05:10 BLUE --Lithium Ionic initiated with bullish view at BMO Capital, here's why » 04:27 LTHCF
This is a Brazil based lithium mine I like. They are hitching into local hydro power damn and have a nice mine located in Minas Gerais state in Brazil. Last month, Lithium Ionic published results that support a long-life and low-cost spodumene concentrate mining project with a post-tax net present value of $1.6 billion. In comparison, the company’s market capitalization is about $140 million. Opportunity? Bandeira Project – Granted Priority Status In July 2023, Lithium Ionic’s projects were granted priority status by the state of Minas Gerais regional government bodies, facilitating the acceleration of approvals and licensing through the development process and paving the way toward mine operation and production. Construction permits are expected to be obtained by mid-2024. Last month, Lithium Ionic’s 100%-owned Brazilian subsidiary, MGLIT Empreendimentos Ltda, entered into an agreement with Cemig Distribuição S.A., the largest electricity distributor in Brazil. With access to Cemig’s low-cost renewable hydroelectric power, Lithium Ionic will be prepared to fast-track Bandeira toward production by utilizing its existing power grid. Lithium Ionic is a Canadian mining company focused on becoming the next significant Brazilian lithium producer. Our properties are located in Brazil’s Minas Gerais state, a mining-friendly jurisdiction that is quickly emerging as a world-class hard-rock lithium-producing district. A recent PEA for the Bandeira Project indicates a long-life, low-cost, and highly profitable project with a Post-tax NPV8% of US$1.6B (~C$2.2B) and IRR of 121%. Our goal is to generate significant returns for our stakeholders by becoming the country's next producer of high-quality spodumene concentrate for the global lithium supply chain.
BLUE- CHART IS STRONG! > 4 RECENT GREEN BARS/ MACD UP / ACC UP/ THE FOOLS- Bluebird Bio is a small-cap gene-editing specialist with two products on the market. The first is Zynteglo, which treats the rare blood disease beta-thalassemia. The second is Skysona, a therapy for cerebral adrenoleukodystrophy, a rare neurodegenerative disease. Bluebird Bio could be about to expand its lineup. The FDA is currently considering lovo-cel for approval. Lovo-cel could earn the green light as a treatment for patients with sickle cell disease, another rare blood disorder, as early as this month. That approval would mean a lot for Bluebird Bio. While Zynteglo and Skysona have a combined target market of at most 1,540 patients in the U.S., lovo-cel's would be more than 10 times that at around 20,000. DAMN THESE ARE SMALL TARGET POPULATIONS----- Further, Bluebird Bio has set the list price for Zynteglo at $2.8 million per treatment course, and priced Skysona at $3 million. We don't know yet how much it will charge for lovo-cel (assuming it's approved), but one thing is for sure: It will be well above $1 million for the one-time therapy. In other words, the market opportunity for Bluebird Bio could be massive, so its shares may jump following the approval of the gene-editing therapy. But does that make Bluebird Bio a buy? WHO CAN AFFORD THIS CRAP! Consider a few things. The company will almost certainly have to share this market from the start with exa-cel, a competing gene-editing treatment for sickle cell disease (which also targets beta-thalassemia). Exa-cel was developed by the team of Vertex Pharmaceuticals and CRISPR Therapeutics. It has yet to earn the green light in the U.S., but it recently won approval in the U.K. as Casgevy. WOW- there are so many reasons NOT to buy this stock it is a buy./ So help me when CRSP gets the go ahead these guys will run... I'm just morally against these prices.
Buying what you see in the street. There is a building that I walk buy that over the years has housed some different internet companies. You can gauge where a Co is in it's lifespan by their flag being here. The names are escaping me at the moment but the last two- once they left they went belly up... anyway the new tech name there is Monday.com? Whatever they are their business is up.
Someone help me out here I THINK THE SAVANT HAS SPOKEN!!!! FOR SOME REASON MONDAY.COM HAS A SHIT TON OF ANALYST ACTION YESTERDAY YET I SEE NO EARNINGS... WHAT GIVES??? Yesterday Monday.com becoming more strategic platform for enterprises, says Goldman Sachs »17:45 MNDY Goldman Sachs keeps a Buy… Monday.com aims to double Annual Contract Value by 2026 »17:42 MNDY Sees significant untapped… Monday.com price target raised to $220 from $205 at TD Cowen »07:24 MNDY TD Cowen raised the… Monday.com price target raised to $227 from $194 at Citi »06:30 MNDY Citi analyst Steven… Monday.com price target raised to $205 from $185 at KeyBanc »06:21 MNDY KeyBanc raised the…
WOA!!! --> a collaborator with multiple Magnificent Seven stocks. TOUCHDOWN!!! With offices across the world, Monday.com has already established a global footprint. Through its workflow automation and productivity platform, the enterprise software firm works with clients across a range of fields, including marketing, sales, HR, and product development. Monday.com collaborates and integrates with firms including Magnificent Seven stocks Microsoft(MSFT) and Alphabet(GOOGL), along with Zoom Video Communications(ZM),HubSpot(HUBS) and more. Through its open platform Monday AI, the company enables clients to build any kind of AI app. Still in beta and with more apps to come, uses range from sentiment analysis to customer experience (CX) chatbots and content generation.
ADD TO WATCH---->monday.com Ltd. (MNDY) NasdaqGS - NasdaqGS Real Time Price. 174.08-2.72 (-1.54%) At close: December 7 04:00PM EST 173.50 -0.58 (-0.33%) Pre-Market: 09:05AM EST
REGARDING. STOCK OF THE WEEK... I'm feeling Flutter.--timing I'm sure is not now-- but I like this name as a hold thru the US listing and beyond I think.. or do I like the listing? There's al ot I don't know here-- like Fanduel will be named Fanduel here I expect-- That's important Flutter is a horrible name... And Flutter gets all kind of cash from this? And/ or are they are not splitting off right? Just duel listing...with a different name?? This is one of the rare cases when belonging to some pay site for info like the old Red Herring which did IPO's way back in the he day.. or was it Red Chip... Ayyyyyyyyyyyy- It would help> Sports betting moves: FanDuel parent preps to list shares in the U.S.